Cargando…

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant

Detalles Bibliográficos
Autores principales:	Zhang, Na-Na, Zhang, Rong-Rong, Zhang, Yi-Fei, Ji, Kai, Xiong, Xiao-Chuan, Qin, Qian-Shan, Gao, Peng, Lu, Xi-Shan, Zhou, Hang-Yu, Song, Hai-Feng, Ying, Bo, Qin, Cheng-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853430/ https://www.ncbi.nlm.nih.gov/pubmed/35165421 http://dx.doi.org/10.1038/s41422-022-00626-w

Ejemplares similares

Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants
por: Fan, Na, et al.
Publicado: (2022)

Neutralization of ARCoV-induced sera against SARS-CoV-2 variants
por: Li, Xiao-Feng, et al.
Publicado: (2022)

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants
por: Sun, Cong, et al.
Publicado: (2022)

Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
por: Wei, Changshuo, et al.
Publicado: (2021)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine
por: Chen, Qian, et al.
Publicado: (2023)

Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters
por: Zhang, Ya-Nan, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
por: Ren, Wenlin, et al.
Publicado: (2023)

Neutralization and Stability of SARS-CoV-2 Omicron Variant
por: Zeng, Cong, et al.
Publicado: (2021)

An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants
por: Shen, Yinzhong, et al.
Publicado: (2022)

Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant
por: Wang, Wei Bu, et al.
Publicado: (2023)

Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open‐label, and single‐arm Phase 1 study
por: Hannawi, Suad, et al.
Publicado: (2023)

mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable Lipids
por: Chen, Kepan, et al.
Publicado: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
por: Li, Fu, et al.
Publicado: (2022)

mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
por: Zhang, Biyan, et al.
Publicado: (2022)

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
por: Tseng, Hung Fu, et al.
Publicado: (2022)

Real-world experience of arbidol for Omicron variant of SARS-CoV-2
por: Zhao, Jingya, et al.
Publicado: (2023)

Anxiety, depression, and somatic symptom disorders in health care workers at high altitude during the rapid spread of the SARS-CoV-2 Omicron variant: A prospective cohort study
por: Feng, Xiaokai, et al.
Publicado: (2023)

Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
por: Li, Gen, et al.
Publicado: (2022)

Clinical Progression and Outcome of Hospitalized Patients Infected with SARS-CoV-2 Omicron Variant in Shanghai, China
por: Shao, Jiasheng, et al.
Publicado: (2022)

Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile
por: Alkhatib, Mohammad, et al.
Publicado: (2022)

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
por: Viana, Raquel, et al.
Publicado: (2022)

“Rapid reinfections with different or same Omicron SARS-CoV-2 sub-variants”
por: Vera-Lise, Ihm, et al.
Publicado: (2022)

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
por: Lu, Changrui, et al.
Publicado: (2023)

COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer
por: Zeng, Cong, et al.
Publicado: (2022)

A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
por: Qin, Shugang, et al.
Publicado: (2023)

Clinical practice of rapid antigen tests for SARS-CoV-2 Omicron variant: A single-center study in China
por: Chen, Mengyuan, et al.
Publicado: (2022)

Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022)

The efficacy of hydrogen/oxygen therapy favored the recovery of omicron SARS-CoV-2 variant infection: results of a multicenter, randomized, controlled trial
por: Shi, Meng-Meng, et al.
Publicado: (2023)

Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice
por: Lu, Ruei-Min, et al.
Publicado: (2023)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
por: Lee, I-Jung, et al.
Publicado: (2022)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Update on omicron variant: What we know so far
por: Choudhary, Gajendra, et al.
Publicado: (2022)

Rapid displacement of SARS-CoV-2 variant Delta by Omicron revealed by allele-specific PCR in wastewater
por: Lee, Wei Lin, et al.
Publicado: (2022)

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
por: Ahava, Maarit J., et al.
Publicado: (2022)

Sensitivity of Rapid Antigen Tests Against SARS-CoV-2 Omicron and Delta Variants
por: Rao, Anuradha, et al.
Publicado: (2023)

Sensitivity of rapid antigen tests against SARS-CoV-2 Omicron and Delta variants
por: Rao, Anuradha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bfp77i5u892jtt75n7e0nscqae